The α2AP-inactivating monoclonal antibody was also demonstrated to increase fibrinolysis in a mouse model of venous thrombosis, suggesting a role for α2AP inhibition in DVT [54]. This evidence concerns the gene SERPINF2 and deep vein thrombosis.